Neurobo Pharmaceuticals company info

What does Neurobo Pharmaceuticals do?
Neurobo Pharmaceuticals (NASDAQ:NRBO) is a dynamic company focused on the development of novel therapies for neurodegenerative, metabolic, and inflammatory diseases. With a commitment to innovation, Neurobo is actively working on several groundbreaking projects, including treatments for Alzheimer's disease, diabetic neuropathy, and other complex conditions. The organization aims to address the urgent need for more effective treatments, striving to improve the quality of life for patients around the world. By leveraging cutting-edge research and strategic partnerships, Neurobo targets to lead advancements in medical science and patient care.
Neurobo Pharmaceuticals company media
Company Snapshot

Is Neurobo Pharmaceuticals a public or private company?

key
Ownership
Public

How many people does Neurobo Pharmaceuticals employ?

people
Employees
8

What sector is Neurobo Pharmaceuticals in?

pie chart
Sector
Health Care

Where is the head office for Neurobo Pharmaceuticals?

location pin
Head Office
Boston, United States

What year was Neurobo Pharmaceuticals founded?

founded flag
Year Founded
2014
What does Neurobo Pharmaceuticals specialise in?
/Nerve Regeneration /Pain Management /Diabetic Neuropathy /Clinical Trials /Innovative Therapies /Pharmaceutical Research

What are the products and/or services of Neurobo Pharmaceuticals?

Overview of Neurobo Pharmaceuticals offerings
Gemcabene, aimed at treating dyslipidemia, a condition characterized by abnormal lipid levels.
Development of therapies targeted towards addressing neurodegenerative diseases such as Alzheimer's.
Investigation into treatments for peripheral artery disease, focusing on improving blood flow.
Exploration of novel drug delivery systems to enhance the efficacy and safety of existing medications.

Who is in the executive team of Neurobo Pharmaceuticals?

Neurobo Pharmaceuticals leadership team
  • Mr. Hyung-Heon  Kim
    Mr. Hyung-Heon Kim
    CEO, President, Principal Executive & Director
  • Mr. Marshall H. Woodworth
    Mr. Marshall H. Woodworth
    CFO, Principal Financial Officer & Principal Accounting Officer
  • Dr. Mi-Kyung  Kim
    Dr. Mi-Kyung Kim
    Chief Scientific Officer
  • Mr. Robert  Homolka
    Mr. Robert Homolka
    Senior Vice President of Clinical Operations